Kewaunee Scientific Corporation logo

Kewaunee Scientific Corporation(KEQU)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL
1-STAR RATING
PASS
LAST CLOSE
$35.7
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for KEQU

11/13/2026: KEQU (1-star) is currently NOT-A-BUY. Pass it for now.

Kewaunee Scientific Corporation is a small-cap industrial manufacturer specializing in laboratory furniture, fume hoods, and technical safety infrastructure for life science and educational markets. The company's primary strengths lie in its century-long brand legacy, customized engineering capabilities, and recent inorganic expansion via Nu Aire, which have driven record revenue scales. Key growth opportunities stem from cross-selling specialized equipment into international research hubs. However, the business faces execution risks, raw material cost pressures, and cyclical exposure to commercial building trends. The stock suits value-oriented investors comfortable with small-cap liquidity dynamics who are willing to monitor order backlog conversion rates and margin stability.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorMixed fitWhile revenue has expanded through acquisitions, organic growth rates remain tied to cyclical commercial building trends.
Momentum investorStrong fit while signal remains positiveThe stock can experience sharp upside movements following robust quarterly earnings releases or major contract announcements.
Value investorStrong fitThe company trades at reasonable valuation multiples relative to its normalized earnings and expanding asset base.
Dividend investorWeak fitKewaunee does not currently prioritize regular dividend distributions, focusing instead on capital reinvestment.
Low-risk investorMixed fitSmall-cap liquidity constraints and exposure to construction cycle volatility introduce moderate risk profile elements.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityMedium / highAs a lower-float small-cap stock, share prices can react sharply to quarterly earnings fluctuations.
Valuation riskMediumValuations are generally reasonable but can disconnect from fundamentals during periods of shifting market sentiment.
Competition risk (specialized lab equipment competitors)MediumIntense competition from peers like Labconco can pressure pricing margins on standard product lines.
Business qualityMedium / highThe company maintains long-standing brand equity and specialized manufacturing know-how in a regulated niche.
Dividend incomeLow / noneIncome-focused investors will find little appeal due to the lack of a consistent dividend yield.
Execution riskMediumSuccessful integration of acquired entities and timely delivery of large international project backlogs are critical to maintaining profitability.

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 103.36M USD
Price to earnings Ratio 12.93
1Y Target Price 28
Price to earnings Ratio 12.93
1Y Target Price 28
Volume (30-day avg) 4.6K shares
Beta 0.82
52 Weeks Range 32.00 - 43.36
Updated Date 11/15/2026
52 Weeks Range 32.00 - 43.36
Updated Date 11/15/2026
Dividends yield (FY) -
Basic EPS (TTM) 2.76

Sector & Industry Intelligence

Sector

Consumer Cyclical

Constructive
Sentiment
Strong Bullish
Momentum
BUY Breadth Improving
BUY participation
67.4%
Active BUY / eligible
31 / 46
30-Day BUY Count Change
+23
Market state
Strong Bullish

More qualifying stocks are receiving or maintaining BUY advisories, indicating improving market participation.

Industry

Furnishings, Fixtures & Appliances

BUY participation
100.0%
Active BUY / eligible
3 / 3
30-Day BUY Count Change
+2

Eligible universe: 3 stocks.

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Downtrend
PRICE PATH

Downtrend

The stock has experienced a sustained decline in price over recent periods.

Moderately Choppy
PRICE STABILITY

Moderately Choppy

The stock has experienced noticeable price swings while retaining some directional structure.

Analysis of Past Performance

Type Stock
Historic Profit 27.53%
Avg. Invested days 39
Today’s Advisory PASS
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 2.0
Stock Returns Performance Upturn Returns Performance icon 3.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
KEQU receives a 3-star rating, supported by solid company fundamentals. The rating is constrained by soft analyst coverage, weak price momentum, and limited analyst upside.

Company Fundamentals

★★★★★
KEQU has solid overall fundamentals (4 stars), with moderate financial health, moderate growth momentum, and solid ownership. In FY2026 versus FY2025, solid cash generation (FCF margin 5.2%) and solid revenue growth (+17.3%) are partially offset by negative earnings growth (-15.7%), soft profitability (net margin 3.4%).

Financial Health Rating

★★★★★
KEQU's financial health is supported by solid liquidity, including working-capital and asset support (WC/assets 32.0%). Profitability is soft (2 stars), which helps explain the 3-star overall score.

Growth Momentum Score

★★★★★
Revenue growth is KEQU's strongest growth driver at +17.3% FY2026 versus FY2025 (solid, 4 stars). By comparison, free-cash-flow growth (+16.5%, solid) is also solid, while earnings growth (-15.7%, negative) holds the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 41.6% and approximately 74.5% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 24.42% supports management-shareholder alignment.

Top 5 Institutional Investors

Northern Trust Corp 8.22%
Dimensional Fund Advisors, Inc. 6.05%
Minerva Advisors LLC 5.16%
Vanguard Capital Management, LLC 3.80%
Punch & Associates Inv Mgmt Inc 3.65%

Unit Economics (Per $1K Revenue)

★★★★★
KEQU generates approximately $285 of gross profit, $59 of operating income, and $52 of free cash flow for every $1,000 of revenue. Based on FY2026 results. Soft margins and solid cash conversion support a 3-star rating, while capital efficiency is moderate.

Economic Dimensions

★★★★★
Effective Tax Rate: 23.80%

Quantitative Style Profile

★★★★★
KEQU has a liquid profile. Weak momentum is the primary drawback.

Style Classification

Quality Focused

Value-OrientedSmall / Mid Cap RiskHighly Liquid / Institution-Friendly

How Company Makes Money

Business areaWhat it includesRetail investor read
Lab Products Group (LPG)Design, manufacture, and installation of steel/wood casework, fume hoods, and modular lab systems for domestic clients.This is the core domestic engine generating the bulk of recurring project-based revenue.
International OperationsForeign subsidiaries and manufacturing facilities fulfilling laboratory infrastructure projects overseas.Provides geographic diversification and taps into high-growth research markets abroad.

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Valuation

Trailing PE 12.93
Forward PE 7.72
Enterprise Value 124.17M
Price to Sales(TTM) 0.37
Enterprise Value 124.17M
Price to Sales(TTM) 0.37
Enterprise Value to Revenue 0.45
Enterprise Value to EBITDA 5.61
Shares Outstanding 2.90M
Shares Floating 2.16M
Shares Outstanding 2.90M
Shares Floating 2.16M
Percent Insiders 24.42
Percent Institutions 41.56

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.